北京绿竹生物技术股份有限公司（股票代码：02480）于2026年9月2日披露的2026年8月股份变动月报表显示，截至2026年8月31日，公司股本结构保持稳定，未有新增发行或股份变动。
报告期内，公司已发行股份总数维持202,449,032股，其中普通股流通股数量为198,913,232股，库存股份为3,535,800股，注册股本总额则继续保持人民币202,449,032元。由于公司于中华人民共和国注册成立，法定股本的概念并不适用，其第一部分公示信息实际为已发行股本。报告显示当月无股份回购、注销或股份期权、股权激励计划及可换股票据、认股权证等方面的变动。
公司在公告中确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规要求。该份月报表由公司秘书刘斯宇签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.